MON-LB101 Pharmacokinetics of Liothyronine during Thyroid Hormone Therapy Withdrawal

Background Liothyronine (LT3) is a substitute for levothyroxine (LT4) for thyroid cancer patients during the preparation for nuclear medicine procedures, and there is renewed interest in its use in combination with LT4 in patients who do not respond to the standard treatment. This therapy is commonl...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Endocr Soc
Main Authors: Celi, Francesco, Wohlford, George, Linderman, Joyce, Smith, Sheila, Yavuz, Sahzene, Pucino, Frank, Van Tassell, Benjamin
Formato: Artigo
Idioma:Inglês
Publicado: Endocrine Society 2019
Assuntos:
Thyroid
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6550962/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-MON-LB101
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares